CAVHANZA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70709-192
  • Package NDC 70709-192-12
  • Application number NDA217379
  • SPL ID 5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3
  • SPL set ID 98b197ea-bca4-427e-8737-97f70a3262bc
  • UNII F41401512X
  • RxCUI 2747509
  • RxCUI 2747516
  • RxCUI 2747518
  • RxCUI 2747520

What the source publishes

Labeler
Cycle Pharmaceuticals Ltd
Active ingredients
Nilotinib
Form
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70709-192_5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3
{
  "name": "CAVHANZA",
  "splId": "5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3",
  "labels": [
    {
      "setId": "98b197ea-bca4-427e-8737-97f70a3262bc",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98b197ea-bca4-427e-8737-97f70a3262bc",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98b197ea-bca4-427e-8737-97f70a3262bc"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cycle Pharmaceuticals Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-192-12)",
      "package_ndc": "70709-192-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260630"
    }
  ],
  "productId": "70709-192_5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3",
  "useDomain": "unknown",
  "dosageForm": "TABLET, ORALLY DISINTEGRATING",
  "productNdc": "70709-192",
  "deaSchedule": null,
  "genericName": "Nilotinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NILOTINIB",
      "strength": "80 mg/1"
    }
  ],
  "applicationNumber": "NDA217379",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260630",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000020009",
      "N0000187062",
      "N0000182137",
      "N0000187064",
      "N0000187063",
      "N0000191272",
      "N0000185503"
    ],
    "upc": [
      "0370709191126"
    ],
    "unii": [
      "F41401512X"
    ],
    "rxcui": [
      "2747509",
      "2747516",
      "2747518",
      "2747520"
    ],
    "spl_set_id": [
      "98b197ea-bca4-427e-8737-97f70a3262bc"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
      "Cytochrome P450 2C8 Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "Cytochrome P450 2C8 Inducers [MoA]",
      "UGT1A1 Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Cycle Pharmaceuticals Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70709-192_5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3"